Antibiotic spectrum index: Difference between revisions
From IDWiki
(added spectrum table) |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 11: | Line 11: | ||
** Penicillin-resistant [[pneumococcus]] (PRP) |
** Penicillin-resistant [[pneumococcus]] (PRP) |
||
** [[Moraxella]] and [[Haemophilus influenzae]] |
** [[Moraxella]] and [[Haemophilus influenzae]] |
||
| − | ** [[Mycoplasma]] and [[Chlamydophila]] |
+ | ** [[Mycoplasma]] and [[Chlamydophila]] (atypicals) |
** [[Anaerobes]] (in general) |
** [[Anaerobes]] (in general) |
||
** [[Bacteriodes fragilis]] (specifically) |
** [[Bacteriodes fragilis]] (specifically) |
||
| Line 17: | Line 17: | ||
* For each patient, the number of points for every antibiotic is added to give a total daily ASI |
* For each patient, the number of points for every antibiotic is added to give a total daily ASI |
||
| − | == |
+ | == Working Ranking == |
| + | |||
| ⚫ | |||
| + | * The following is a reasonable list of commonly-used antibiotics, order from broadest to narrowest, not based on the ASI |
||
| + | * [[Cefiderocol]], [[Colistin]], [[Polymyxin B]], [[Meropenem-vaborbactam]], [[Imipenem-relebactam]], [[Ceftazidime-avibactam]], [[Ceftolozane-tazobactam]], [[Tigecycline]], [[Meropenem]], [[Doripenem]], [[Ertapenem]], [[Piperacillin-tazobactam]], [[Ticarcillin-clavulanate]], [[Fosfomycin]], [[Moxifloxacin]], [[Levofloxacin]], [[Ciprofloxacin]], [[Doxycycline]], [[Amikacin]], [[Tobramycin]], [[Gentamicin]], [[Cefipime]], [[Ceftazidime]], [[Trimethoprim-sulfamethoxazole]], [[Ampicillin-sulbactam]], [[Amoxicillin-clavulanate]], [[Ceftaroline]], [[Ceftriaxone]], [[Cefuroxime]], [[Cefazolin]], [[Ampicillin]], [[Amoxicillin]] |
||
| + | |||
| + | == Sample Spectrum Index == |
||
| ⚫ | |||
!Antibiotic |
!Antibiotic |
||
!MSSA |
!MSSA |
||
| + | !E.faeca |
||
| − | !Enterococcus |
||
!Anaerobes |
!Anaerobes |
||
!Bacteroides |
!Bacteroides |
||
| + | !M/H.flu |
||
| − | !Moraxella/Haemophilus |
||
| + | !E/K |
||
| − | !Escherichia/Klebsiella |
||
!AmpC |
!AmpC |
||
!ESBL |
!ESBL |
||
| + | !Pseudo |
||
| − | !Pseudomonas |
||
!MRSA |
!MRSA |
||
| + | !PRP |
||
| − | !Pen-R pneumococcus |
||
!VRE |
!VRE |
||
| + | !Atypicals |
||
| − | !Atypical |
||
!MDRO |
!MDRO |
||
!ASI |
!ASI |
||
|- |
|- |
||
| − | |Dicloxacillin |
+ | |[[Dicloxacillin]] |
|1 |
|1 |
||
|0 |
|0 |
||
| Line 53: | Line 58: | ||
|1 |
|1 |
||
|- |
|- |
||
| − | |Oxacillin |
+ | |[[Oxacillin]] |
|1 |
|1 |
||
|0 |
|0 |
||
| Line 70: | Line 75: | ||
|1 |
|1 |
||
|- |
|- |
||
| − | |Amoxicillin |
+ | |[[Amoxicillin]] |
|0 |
|0 |
||
|1 |
|1 |
||
| Line 87: | Line 92: | ||
|2 |
|2 |
||
|- |
|- |
||
| − | |Ampicillin |
+ | |[[Ampicillin]] |
|0 |
|0 |
||
|1 |
|1 |
||
| Line 104: | Line 109: | ||
|2 |
|2 |
||
|- |
|- |
||
| − | |Cephalexin |
+ | |[[Cephalexin]] |
|1 |
|1 |
||
|0 |
|0 |
||
| Line 121: | Line 126: | ||
|2 |
|2 |
||
|- |
|- |
||
| − | |Erythromycin |
+ | |[[Erythromycin]] |
|0 |
|0 |
||
|0 |
|0 |
||
| Line 138: | Line 143: | ||
|2 |
|2 |
||
|- |
|- |
||
| − | |Erythromycin |
+ | |[[Erythromycin]] |
|0 |
|0 |
||
|0 |
|0 |
||
| Line 155: | Line 160: | ||
|2 |
|2 |
||
|- |
|- |
||
| − | |Metronidazole |
+ | |[[Metronidazole]] |
|0 |
|0 |
||
|0 |
|0 |
||
| Line 172: | Line 177: | ||
|2 |
|2 |
||
|- |
|- |
||
| − | |Penicillin |
+ | |[[Penicillin]] |
|0 |
|0 |
||
|1 |
|1 |
||
| Line 189: | Line 194: | ||
|2 |
|2 |
||
|- |
|- |
||
| − | |Aztreonam |
+ | |[[Aztreonam]] |
|0 |
|0 |
||
|0 |
|0 |
||
| Line 206: | Line 211: | ||
|3 |
|3 |
||
|- |
|- |
||
| − | |Cefazolin |
+ | |[[Cefazolin]] |
|1 |
|1 |
||
|0 |
|0 |
||
| Line 223: | Line 228: | ||
|3 |
|3 |
||
|- |
|- |
||
| − | |Cefdinir |
+ | |[[Cefdinir]] |
|1 |
|1 |
||
|0 |
|0 |
||
| Line 240: | Line 245: | ||
|3 |
|3 |
||
|- |
|- |
||
| − | |Cefixime |
+ | |[[Cefixime]] |
|0 |
|0 |
||
|0 |
|0 |
||
| Line 257: | Line 262: | ||
|3 |
|3 |
||
|- |
|- |
||
| − | |Cefpodoxime |
+ | |[[Cefpodoxime]] |
|1 |
|1 |
||
|0 |
|0 |
||
| Line 274: | Line 279: | ||
|3 |
|3 |
||
|- |
|- |
||
| − | |Rifampin |
+ | |[[Rifampin]] |
|1 |
|1 |
||
|0 |
|0 |
||
| Line 291: | Line 296: | ||
|3 |
|3 |
||
|- |
|- |
||
| − | |Azithromycin |
+ | |[[Azithromycin]] |
|1 |
|1 |
||
|0 |
|0 |
||
| Line 308: | Line 313: | ||
|4 |
|4 |
||
|- |
|- |
||
| − | |Cefprozil |
+ | |[[Cefprozil]] |
|1 |
|1 |
||
|0 |
|0 |
||
| Line 325: | Line 330: | ||
|4 |
|4 |
||
|- |
|- |
||
| − | |Ceftazidime |
+ | |[[Ceftazidime]] |
|0 |
|0 |
||
|0 |
|0 |
||
| Line 342: | Line 347: | ||
|4 |
|4 |
||
|- |
|- |
||
| − | |Cefuroxime |
+ | |[[Cefuroxime]] |
|1 |
|1 |
||
|0 |
|0 |
||
| Line 359: | Line 364: | ||
|4 |
|4 |
||
|- |
|- |
||
| − | |Chloramphenicol |
+ | |[[Chloramphenicol]] |
|0 |
|0 |
||
|0 |
|0 |
||
| Line 376: | Line 381: | ||
|4 |
|4 |
||
|- |
|- |
||
| − | |Clarithromycin |
+ | |[[Clarithromycin]] |
|1 |
|1 |
||
|0 |
|0 |
||
| Line 393: | Line 398: | ||
|4 |
|4 |
||
|- |
|- |
||
| − | |Clindamycin |
+ | |[[Clindamycin]] |
|1 |
|1 |
||
|0 |
|0 |
||
| Line 410: | Line 415: | ||
|4 |
|4 |
||
|- |
|- |
||
| − | |Piperacillin |
+ | |[[Piperacillin]] |
|0 |
|0 |
||
|1 |
|1 |
||
| Line 427: | Line 432: | ||
|4 |
|4 |
||
|- |
|- |
||
| + | |[[TMP-SMX]] |
||
| − | |Trimethoprim- sulfamethoxazole |
||
|1 |
|1 |
||
|0 |
|0 |
||
| Line 444: | Line 449: | ||
|4 |
|4 |
||
|- |
|- |
||
| − | |Cefotaxime |
+ | |[[Cefotaxime]] |
|1 |
|1 |
||
|0 |
|0 |
||
| Line 461: | Line 466: | ||
|5 |
|5 |
||
|- |
|- |
||
| − | |Cefoxitin |
+ | |[[Cefoxitin]] |
|1 |
|1 |
||
|0 |
|0 |
||
| Line 478: | Line 483: | ||
|5 |
|5 |
||
|- |
|- |
||
| − | |Ceftriaxone |
+ | |[[Ceftriaxone]] |
|1 |
|1 |
||
|0 |
|0 |
||
| Line 495: | Line 500: | ||
|5 |
|5 |
||
|- |
|- |
||
| + | |[[Colistin]] |
||
| − | |Colistimethate |
||
|0 |
|0 |
||
|0 |
|0 |
||
| Line 512: | Line 517: | ||
|5 |
|5 |
||
|- |
|- |
||
| − | |Daptomycin |
+ | |[[Daptomycin]] |
|1 |
|1 |
||
|1 |
|1 |
||
| Line 529: | Line 534: | ||
|5 |
|5 |
||
|- |
|- |
||
| − | |Doxycycline |
+ | |[[Doxycycline]] |
|1 |
|1 |
||
|0 |
|0 |
||
| Line 546: | Line 551: | ||
|5 |
|5 |
||
|- |
|- |
||
| − | |Gentamicin |
+ | |[[Gentamicin]] |
|1 |
|1 |
||
|0 |
|0 |
||
| Line 563: | Line 568: | ||
|5 |
|5 |
||
|- |
|- |
||
| − | |Minocycline |
+ | |[[Minocycline]] |
|1 |
|1 |
||
|0 |
|0 |
||
| Line 580: | Line 585: | ||
|5 |
|5 |
||
|- |
|- |
||
| − | |Telavancin |
+ | |[[Telavancin]] |
|1 |
|1 |
||
|1 |
|1 |
||
| Line 597: | Line 602: | ||
|5 |
|5 |
||
|- |
|- |
||
| − | |Tobramycin |
+ | |[[Tobramycin]] |
|1 |
|1 |
||
|0 |
|0 |
||
| Line 614: | Line 619: | ||
|5 |
|5 |
||
|- |
|- |
||
| − | |Vancomycin |
+ | |[[Vancomycin]] |
|1 |
|1 |
||
|1 |
|1 |
||
| Line 631: | Line 636: | ||
|5 |
|5 |
||
|- |
|- |
||
| − | |Amikacin |
+ | |[[Amikacin]] |
|1 |
|1 |
||
|0 |
|0 |
||
| Line 648: | Line 653: | ||
|6 |
|6 |
||
|- |
|- |
||
| − | |Amoxicillin- |
+ | |[[Amoxicillin-clavulanic acid]] |
|1 |
|1 |
||
|1 |
|1 |
||
| Line 665: | Line 670: | ||
|6 |
|6 |
||
|- |
|- |
||
| − | |Ampicillin-sulbactam |
+ | |[[Ampicillin-sulbactam]] |
|1 |
|1 |
||
|1 |
|1 |
||
| Line 682: | Line 687: | ||
|6 |
|6 |
||
|- |
|- |
||
| − | |Cefepime |
+ | |[[Cefepime]] |
|1 |
|1 |
||
|0 |
|0 |
||
| Line 699: | Line 704: | ||
|6 |
|6 |
||
|- |
|- |
||
| − | |Linezolid |
+ | |[[Linezolid]] |
|1 |
|1 |
||
|1 |
|1 |
||
| Line 716: | Line 721: | ||
|6 |
|6 |
||
|- |
|- |
||
| − | |Ticarcillin-clavulanate |
+ | |[[Ticarcillin-clavulanate]] |
|1 |
|1 |
||
|0 |
|0 |
||
| Line 733: | Line 738: | ||
|6 |
|6 |
||
|- |
|- |
||
| − | |Ceftaroline |
+ | |[[Ceftaroline]] |
|1 |
|1 |
||
|1 |
|1 |
||
| Line 750: | Line 755: | ||
|8 |
|8 |
||
|- |
|- |
||
| − | |Ciprofloxacin |
+ | |[[Ciprofloxacin]] |
|1 |
|1 |
||
|1 |
|1 |
||
| Line 767: | Line 772: | ||
|8 |
|8 |
||
|- |
|- |
||
| − | |Piperacillin-tazobactam |
+ | |[[Piperacillin-tazobactam]] |
|1 |
|1 |
||
|1 |
|1 |
||
| Line 784: | Line 789: | ||
|8 |
|8 |
||
|- |
|- |
||
| − | |Ertapenem |
+ | |[[Ertapenem]] |
|1 |
|1 |
||
|0 |
|0 |
||
| Line 801: | Line 806: | ||
|9 |
|9 |
||
|- |
|- |
||
| − | |Levofloxacin |
+ | |[[Levofloxacin]] |
|1 |
|1 |
||
|1 |
|1 |
||
| Line 818: | Line 823: | ||
|9 |
|9 |
||
|- |
|- |
||
| − | |Meropenem |
+ | |[[Meropenem]] |
|1 |
|1 |
||
|0 |
|0 |
||
| Line 835: | Line 840: | ||
|10 |
|10 |
||
|- |
|- |
||
| − | |Moxifloxacin |
+ | |[[Moxifloxacin]] |
|1 |
|1 |
||
|1 |
|1 |
||
| Line 852: | Line 857: | ||
|10 |
|10 |
||
|- |
|- |
||
| − | |Imipenem-cilastatin |
+ | |[[Imipenem-cilastatin]] |
|1 |
|1 |
||
|1 |
|1 |
||
| Line 869: | Line 874: | ||
|11 |
|11 |
||
|- |
|- |
||
| − | |Tigecycline |
+ | |[[Tigecycline]] |
|1 |
|1 |
||
|1 |
|1 |
||
| Line 886: | Line 891: | ||
|13 |
|13 |
||
|} |
|} |
||
| + | MSSA = methicillin-susceptible [[Staphylococcus aureus]]; E/K = [[Escherichia coli]]/[[Klebsiella]]; M/H.flu = [[Moraxella]] and [[Haemophilus influenzae]]; Pseudo = [[Pseudomonas aeruginosa]]; MRSA = [[methicillin-resistant Staphylococcus aureus]]; PRP = penicillin-resistant [[pneumococcus]]; VRE = vancomycin-resistant [[Enterococcus]]; atypicals = [[Mycoplasma pneumoniae]] and [[Chlamidophila]]; MDRO = multidrug-resistant organisms |
||
==Further Reading== |
==Further Reading== |
||
Latest revision as of 14:34, 4 April 2024
- Measures the spectrum of an antibiotic, with a range from 0 to 14
- One point for activity against each of the following:
- Methicillin-sensitive Staphylococcus aureus (MSSA)
- Methicillin-resistant Staphylococcus aureus (MRSA)
- Enterococcus faecalis
- Vancomycin-resistant Enterococcus faecalis (VRE)
- Escherichia coli or Klebsiella
- AmpC producers (Enterobacter, Serratia, and Citrobacter)
- Extended-spectrum β-lactamase (ESBL) E. coli/Klebsiella
- Pseudomonas aeruginosa
- Penicillin-resistant pneumococcus (PRP)
- Moraxella and Haemophilus influenzae
- Mycoplasma and Chlamydophila (atypicals)
- Anaerobes (in general)
- Bacteriodes fragilis (specifically)
- Multidrug-resistant organisms
- For each patient, the number of points for every antibiotic is added to give a total daily ASI
Working Ranking
- The following is a reasonable list of commonly-used antibiotics, order from broadest to narrowest, not based on the ASI
- Cefiderocol, Colistin, Polymyxin B, Meropenem-vaborbactam, Imipenem-relebactam, Ceftazidime-avibactam, Ceftolozane-tazobactam, Tigecycline, Meropenem, Doripenem, Ertapenem, Piperacillin-tazobactam, Ticarcillin-clavulanate, Fosfomycin, Moxifloxacin, Levofloxacin, Ciprofloxacin, Doxycycline, Amikacin, Tobramycin, Gentamicin, Cefipime, Ceftazidime, Trimethoprim-sulfamethoxazole, Ampicillin-sulbactam, Amoxicillin-clavulanate, Ceftaroline, Ceftriaxone, Cefuroxime, Cefazolin, Ampicillin, Amoxicillin
Sample Spectrum Index
| Antibiotic | MSSA | E.faeca | Anaerobes | Bacteroides | M/H.flu | E/K | AmpC | ESBL | Pseudo | MRSA | PRP | VRE | Atypicals | MDRO | ASI |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dicloxacillin | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Oxacillin | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Amoxicillin | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| Ampicillin | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| Cephalexin | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| Erythromycin | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 2 |
| Erythromycin | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 2 |
| Metronidazole | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| Penicillin | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| Aztreonam | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 3 |
| Cefazolin | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
| Cefdinir | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
| Cefixime | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
| Cefpodoxime | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
| Rifampin | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 3 |
| Azithromycin | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 4 |
| Cefprozil | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 |
| Ceftazidime | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 4 |
| Cefuroxime | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 |
| Chloramphenicol | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 |
| Clarithromycin | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 4 |
| Clindamycin | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 4 |
| Piperacillin | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 4 |
| TMP-SMX | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 4 |
| Cefotaxime | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 5 |
| Cefoxitin | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 |
| Ceftriaxone | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 5 |
| Colistin | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 5 |
| Daptomycin | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 5 |
| Doxycycline | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 5 |
| Gentamicin | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 5 |
| Minocycline | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 5 |
| Telavancin | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 5 |
| Tobramycin | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 5 |
| Vancomycin | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 5 |
| Amikacin | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 6 |
| Amoxicillin-clavulanic acid | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 |
| Ampicillin-sulbactam | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 |
| Cefepime | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 6 |
| Linezolid | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 6 |
| Ticarcillin-clavulanate | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6 |
| Ceftaroline | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 8 |
| Ciprofloxacin | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 8 |
| Piperacillin-tazobactam | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 8 |
| Ertapenem | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 9 |
| Levofloxacin | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 9 |
| Meropenem | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 10 |
| Moxifloxacin | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 10 |
| Imipenem-cilastatin | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 11 |
| Tigecycline | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 13 |
MSSA = methicillin-susceptible Staphylococcus aureus; E/K = Escherichia coli/Klebsiella; M/H.flu = Moraxella and Haemophilus influenzae; Pseudo = Pseudomonas aeruginosa; MRSA = methicillin-resistant Staphylococcus aureus; PRP = penicillin-resistant pneumococcus; VRE = vancomycin-resistant Enterococcus; atypicals = Mycoplasma pneumoniae and Chlamidophila; MDRO = multidrug-resistant organisms
Further Reading
- Development and Application of an Antibiotic Spectrum Index for Benchmarking Antibiotic Selection Patterns Across Hospitals. Infect Control Hosp Epidemiol. 2017;38(8):993-997. doi: 10.1017/ice.2017.94.
